Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$4.85 - $9.73 $75,485 - $151,437
-15,564 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$4.93 - $6.46 $237,310 - $310,958
-48,136 Reduced 75.57%
15,564 $85,000
Q1 2021

May 14, 2021

SELL
$5.24 - $6.99 $25,932 - $34,593
-4,949 Reduced 7.21%
63,700 $380,000
Q4 2020

Feb 02, 2021

SELL
$4.77 - $6.58 $6,200 - $8,554
-1,300 Reduced 1.86%
68,649 $358,000
Q3 2020

Nov 05, 2020

BUY
$4.36 - $5.5 $55,372 - $69,850
12,700 Added 22.18%
69,949 $339,000
Q2 2020

Aug 12, 2020

BUY
$3.6 - $7.75 $206,096 - $443,679
57,249 New
57,249 $297,000

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $446M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.